Bioton (LTS:0DTR) Short Interest


LTS:0DTR Bioton SA LTS:0DTR
68 GF Score
Price zł3.43
GF Value zł4.08
! 3 Warning Signs
View Full Analysis

What is Bioton Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


LTS:0DTR vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Bioton's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioton Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioton's Short Interest distribution charts can be found below:

* The bar in red indicates where Bioton's Short Interest falls into.


LTS:0DTR
68GF Score
Bioton SA LTS:0DTR
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bioton (LTS:0DTR) Overvalued in 2026?

Based on GuruFocus' analysis, Bioton stock appears to be undervalued. The current stock price of zł3.43 is trading 16% below its estimated GF Value™ of zł4.08.

Key valuation signals for LTS:0DTR:

  • Short Interest:
  • GF Value™: zł4.08 vs. price of zł3.43 (16% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the LTS:0DTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bioton Business Description

Other Exchanges BIO:Poland7U5:Germany
Address Ul. Starościńska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.
68GF Score

Get the complete analysis for LTS:0DTR

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł3.43
Price
zł4.08
GF Value